Brief Report: A phase IIa, randomized, double‐blind, placebo‐controlled trial of apilimod mesylate, an interleukin‐12/interleukin‐23 inhibitor, in patients with rheumatoid arthritis
| Image |  |
|---|---|
| Description | scientific article published on December 14, 2011 |
| Author/s |
author: Paul P Tak |
| Publication date | December 14, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.34339 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |